Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Total 13F shares
-
2,493,881
-
Share change
-
+47,795
-
Total reported value
-
$5,085,134
-
Put/Call ratio
-
233%
-
Price per share
-
$2.04
-
Number of holders
-
28
-
Value change
-
-$58,440
-
Number of buys
-
13
-
Number of sells
-
10
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q4 2021
As of 31 Dec 2021,
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,493,881 shares.
The largest 10 holders included
ARK Investment Management LLC, Parkman Healthcare Partners LLC, MORGAN STANLEY, PVG ASSET MANAGEMENT CORP, ENVESTNET ASSET MANAGEMENT INC, LPL Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Jump Financial, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Geneos Wealth Management Inc..
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.